Related Experiment Videos
[Ageing men's sexual functions decline and the erectile dysfunction (ED) increase]
Edouard Amar1, Thierry Grivel, Karim Hamidi
1Service d'Urologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
Summary
Low testosterone levels in aging men may impact erectile function. Testosterone replacement therapy can improve erectile function and enhance the effectiveness of PDE5 inhibitors in hypogonadal patients.
Area of Science:
- Endocrinology
- Urology
- Andrology
Context:
- Aging men often experience declining androgen levels.
- The direct link between falling androgens and erectile dysfunction (ED) is not fully established.
- Erectile function is influenced by multiple physiological factors.
Purpose:
- To analyze the existing literature on the association between androgen levels and erectile function in aging men.
- To investigate the role of androgens in modulating erectile function.
- To evaluate the impact of testosterone replacement therapy (TRT) on ED, particularly in hypogonadal men.
Summary:
- Androgens play a significant role in erectile function, affecting penile innervation, smooth muscle, endothelial function, and corpus cavernosum properties.
- Testosterone replacement therapy (TRT) can improve outcomes for many men with androgen deficiency in aging males (ADAM).
- Hypogonadal men may not respond optimally to phosphodiesterase type 5 (PDE5) inhibitors alone; TRT can enhance their efficacy.
Impact:
- Clarifies the androgenomodulation of erectile function.
- Highlights the potential benefits of TRT for aging men with ED and hypogonadism.
- Suggests a combined therapeutic approach for improved ED management in specific patient populations.